Latest Financials News

Nexion Group has agreed to sell its telecommunications subsidiaries for $4.1 million, aiming to reduce debt and pivot towards its high-growth AI and business intelligence operations.

Atlas Pearls Ltd reported a 6% revenue increase to $44.3 million in FY25 despite a 30% drop in net profit, unveiling a strategic roadmap targeting up to 50% production growth by FY30 alongside a fully franked dividend.

Civmec Limited posted solid FY25 results with $810.6 million revenue and a strategic acquisition boosting its naval shipbuilding footprint. The company’s $1.25 billion order book and focus on low-carbon sectors set the stage for growth.

Civmec Limited reported solid FY2025 financials with revenue surpassing A$810 million and a strengthened order book of A$1.25 billion, underpinned by its strategic acquisition of Luerssen Australia.

Civmec Limited reported a 21.6% drop in revenue and a 34% fall in net profit for FY2025, reflecting the impact of completed contracts. Despite this, the company maintained steady margins and increased its cash reserves, signaling resilience and ongoing growth potential.

Adriatic Metals Plc shares have been suspended from the ASX to facilitate its proposed acquisition by Dundee Precious Metals Inc. under a UK scheme of arrangement.

Experience Co Limited reports a robust FY25 with revenue growth and a significant jump in earnings, driven by a tourism rebound in Australia and New Zealand.

Clean TeQ Water Limited reported a reduced loss of $2.8 million for FY25 and increased its stake in Go2Lithium Inc to 60%, marking a strategic shift as it advances water treatment and critical metals recovery projects worldwide.

Experience Co Limited reported a solid FY25 financial performance with revenue rising 6% to $134.3 million and underlying EBITDA jumping 34%, driven by strong recovery in skydiving and adventure segments. The company declared a fully franked dividend and outlined an optimistic FY26 outlook focused on growth and efficiency.

BDO Audit has completed its review of HeraMED Limited’s half-year financial report for June 2025, confirming compliance with accounting standards but highlighting significant uncertainty over the company’s ability to continue as a going concern.

BlinkLab Limited reported a substantial net loss of $5.7 million for FY2025, driven by intensive R&D and clinical trial activities, while securing $7.66 million in fresh capital to fuel its smartphone-based neurodevelopmental diagnostic platform targeting autism and ADHD.

Cynata Therapeutics reported a $9.39 million net loss for FY2025, slightly improved from the prior year, while progressing multiple clinical trials with key results expected in 2026. The company maintains a solid cash position and funding runway through mid-2026, supported by recent capital raises and an equity subscription agreement.